Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-01-22

Clinical Trial Update: Lacripep™ in Subjects With Dry Eye Associated With Primary Sjögren's Syndrome [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial update for Lacripep in dry eye associated with Primary Sjögren's Syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lacripep

Snippet

Sponsor: TearSolutions, Inc. | Conditions: Primary Sjögren Syndrome, Dry Eye | Phase 1, Phase 2 | Status: COMPLETED